Skip to main content

Table 1 Baseline population characteristics

From: Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial

 

Total population (n = 10)

General characteristics

 Gender, male; n (%)

9 (90)

 Age, years; mean (SD)

71.7 (6)

 Former smoker, n (%)

8 (80)

 BMI, kg/m2; mean (SD)

28.5 (5)

 GAP index, median (p25-p75)

3 (2–3)

Treatments, n (%)

 Antifibrotic therapy

9 (90)

 Ambulatory oxygen therapy on exertion

8 (80)

 Ambulatory 24-h oxygen therapy

4 (40)

Comorbidities, n (%)

 Hypertension

4 (40)

 Dyslipidemia

4 (40)

 Diabetes mellitus

3 (30)

 Sleep apnea

2 (20)

 Ischemic heart disease

2 (20)

 Pulmonary emphysema

2 (20)

 Pulmonary hypertensiona

4 (40)

 Charlson comorbidity index; mean (SD)

4.1 (1.2)

Pulmonary function tests, mean (SD)

 FEV1, % pred

62 (13)

 FVC, % pred

58 (11)

 DLCO, % pred

31 (13)

6-min walking test, mean (SD)

 Distance, m

436 (131)

 Distance, % pred

90 (20)

 Initial SpO2, %

91 (4)

 Minimum SpO2, %

76 (7)

 Mean SpO2, %

81 (4)

 ΔSpO2, %b

− 18 (10)

Peripheral muscle strength, mean (SD)

 Quadriceps strength, kg

41 (14)

 Quadriceps strength, % pred

109 (39)

 Hand-grip, kg

30 (12)

 Hand-grip, % pred

111 (30)

  1. BMI body mass index, GAP gender age physiology, FEV1 expiratory flow in the first second, FVC forced vital capacity, DLCO carbon monoxide diffusion capacity, SpO2 peripheral oxygen saturation
  2. aPulmonary hypertension was assessed by echocardiography (systolic pulmonary artery pressure > 35 mm Hg)
  3. bΔSpO2%, percentage of change between baseline and exercise values